Summer 2024 was one of the hardest stretches of my life, and I say that as someone who started residency training (June 2020) during a global pandemic.
I finished residency in June, started both my Behavioral Neurology and Neuropsychiatry (BNNP) fellowship at Johns Hopkins and the NIH/NINDS Clinical Fellowship the following week, and got married to my best friend on July 13th. On paper, it sounds like a season of celebration. And it was! But it was also a lot. July 13, 2024
Starting TWO new fellowships while simultaneously settling into a new marriage and a new home meant that I had almost no time to just breathe. The onboarding process for both fellowships was, to put it generously, a disaster. I spent weeks navigating bureaucratic confusion at TWO sites, wrong buildings, wrong offices, and a general sense that no one quite knew what to do with me or where I was supposed to be. I remember one afternoon in particular when I drove to three different locations on the Hopkins campus, trying to get a badge and sweating through my clothes in the 100 degree summer heat.
It was a lot. Marriage is hard, and I won't pretend ours was immune to the pressures of that season. My husband and I were building a life together while both starting new jobs and adjusting to a new city. Overall, though, I'm grateful to have married my best friend.
The BNNP Fellowship
The Behavioral Neurology and Neuropsychiatry fellowship was not what I expected. I have genuine gratitude for the experience.
I had to structure a significant portion of my own learning. There were stretches where, if I had waited for the curriculum to come to me, I would have learned very little. That was hard to accept at first. But it ended up being a blessing. I dug deep to figure out what I actually wanted and needed to get out of this 2-year training. I defined four concrete learning goals for myself, identified the resources that would help me meet them, and started treating the fellowship less like something that was happening to me and more like something I was actively building.
What the fellowship gave me, even in its imperfect form, was irreplaceable. I genuinely love dementia care. I love the nuance of it, the detective work, and the long conversations with patients and families about what matters most to them and what their life looks like now. I also became a much better communicator, thanks to the help of my Psychiatry colleagues, and not just in the clinical sense. Because I was immersed in behavioral neurology and neuropsychiatry for two years, this has made me more patient, more curious about people, and honestly, more gracious in my personal life too.
There has been one area of disillusionment, to be honest: anti-amyloid therapies for Alzheimer's disease. There is so much excitement in the field, but the more time I spent in the Hopkins Memory Clinic (and tuning in to meetings/conferences involving other institutions), the more I doubted the craze and genuine utility of these new drugs. At the American Academy of Neurology 2025 Annual Meeting, I asked a panel of experts to share patient narratives of meaningful improvement. The answers were thin. "We give patients hope," one person said. That is not nothing, but it is also not enough. I am not ready to hang my hat on therapies that cost hundreds of thousands of dollars and offer, in many cases, modest benefit. Maybe that's heresy to say as a behavioral neurologist, but frankly, I think we can do better, and that's a big part of why I do the research I do.
Patients Who Have Stayed With Me
*To ensure HIPAA compliance, personally identifying information has been omitted/changed and certain details of these encounters have been modified to protect the patients and their families.
More than just a "memory problem"
I first met this patient in the fall of 2024. She was 75 years old, had a history of recurrent depression, fibromyalgia, severe COVID pneumonia in 2021, and a whole constellation of symptoms that had been accumulating for years. She came to us with worsening memory, word-finding difficulties, and visual hallucinations. She described seeing people who were not there, including a woman in the mirror and a man on the ceiling. It sounded terrifying.
All labs were normal. Her neuropsychological testing was puzzling. Most of her cognitive performance was normal, but there were some deficits in attention, visual memory and inconsistencies in executive function. Her MRI showed bilateral hippocampal atrophy and an old cerebellar infarct. On paper, you could probably convince yourself you were looking at early neurodegeneration. We ordered an FDG-PET scan and sent her home to wait.
When she came back several months later, I sat with her and her daughter and went through everything again carefully. Unfortunately, she wasn't able to get the FDG-PET scan due to insurance issues and a recent hospitalization for dehydration and "failure to thrive" (she wasn't eating). However, it turns out we didn't need it anymore.
My clinical thinking and practice improved by the time of this follow-up visit. I'd recently spent months on inpatient geriatric psychiatry and saw more in-depth cases of severe depression in older adults. I looked at this patient again, re-reviewed the history, and it clicked. She was spending sixteen hours a day in bed (hypersomnia). She had stopped knitting, stopped reading, stopped playing cards. She had lost interest in everything that used to make her feel like herself (anhedonia). She was feeling guilty, eating minimally, expressed a passive death wish, and had visual hallucinations that weren't as well formed as what we'd expect in primary neurologic disorders. Her mood was what we should've focused on at the beginning.
I told her, "Your memory is being significantly affected by depression. If we can get that under better control, we're going to see things improve." She looked at me for a moment and then her daughter. Her daughter started crying.
"Depression? So she doesn't have dementia?" the daughter asked.
I spent some time explaining that dementia was a syndrome (impaired cognition and functional abilities, such as independently managing medications or finances) that could be due to so many things, including depression, Alzheimer's Disease, and heck, even horrific, untreated insomnia could do it. In this patient's case, she certainly may have had an underlying neurodegenerative process brewing and in its early stages (e.g., Alzheimer's Disease, vascular dementia), but the depression was unmistakably the driving force for her dementia.
I increased her Wellbutrin, encouraged her to meet with one of our psychologists, and brainstormed with the patient and daughter ways to get the patient back into the activities she once loved. Over the next several months, she got better. Not all the way better, and not overnight, but meaningfully, unmistakably better.
The physician who deserved the truth
This case is harder to tell. I was on the neurology consult service at the National Institutes of Health (NIH) when I was asked to see a 47-year-old woman from Latin America who was admitted for a seizure workup. She had a known brain tumor (glioblastoma multiforme), and the team wanted guidance on her antiseizure medication.
I walked into that room expecting a straightforward consult. What I found was something else entirely.
She was a practicing physician back home. She was warm, articulate, and utterly convinced she was fine. But within minutes of talking with her, I knew she was not fine. Her thinking was disorganized in ways she could not detect. Her MRI of the brain, which I reviewed carefully before going in, looked like the brain of someone decades older. The atrophy, the changes, and just the overall picture were devastating. She had dementia that was advanced enough that I had no doubt.
What stunned me was the silence around her dementia diagnosis, not her brain tumor diagnosis. Her brother was a physician himself and involved in her care. Her oncologist back home had been seeing her for years. Multiple teams had touched her chart. And as far as I could tell, no one had sat down with her and said, "You should not be practicing medicine anymore."
So I did it myself.
It was one of the hardest conversations I've ever had. She pushed back at first. Her brother sat beside her, quiet, taking it all in. I told her gently but directly that her current cognitive state made it unsafe for her to be responsible for patients, and that continuing to practice would put both her and the people in her care at risk. I told her that this was not a reflection of who she had been as a physician, or of her intelligence, or of her life's work. It was simply where things were now.
She was quiet for a long time after that.
I left that room feeling heavy but clear. Being the first person to tell a patient something true and necessary is not a comfortable place to stand, but it's exactly where we are supposed to be.
The Research
On the research side, these two years were enormously productive. I am very grateful for that. I had been working in the NIA intramural lab of Dr. Keenan Walker (ADRD biomarker and proteomics expert) and currently with Dr. Roland Thorpe in the Hopkins School of Public Health for my post-doctoral research fellowship. My work focuses on epidemiologic approaches to examine early-life adversity, psychosocial determinants, and cognitive aging trajectories in diverse older adult populations (or I suppose I should say "nationally representative" or "sociodemographically varied", since the word "diverse" has been banned in grant applications by our government). The big goal is to understand what drives cognitive resilience and decline in people who have experienced early life adversity, and to eventually develop tools that can identify who is at greatest risk before significant damage is done.
What's Next
I recently began a postdoctoral research fellowship at the Johns Hopkins Bloomberg School of Public Health. I get to spend a full year embedded with some of the top epidemiologists and researchers in the field of cognitive aging, and I could not be more grateful for this opportunity.
I am also in the final stages of a major career decision. I have several cognitive neurology faculty offers on the table, and making this choice has felt like the culmination of more than a decade of work. I do not take that lightly. Wherever I land, I will be building the lab and the program I have been dreaming about since I was a medical student who barely understood what research was.
And sometime in the summer of 2027, my husband and I will pack up everything we have built in Maryland and move to start the next chapter of our lives.




















